Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief

The Centers for Medicare & Medicaid Services Innovation Center was born to create positive disruption to the financing and delivery of care. Its latest program may be the most likely to succeed (or fail).

AI is not “future state” anymore. It’s current state. Better get on board.

This century has seen a dramatic shortage of pharmacists, then a dramatic pullback, and now a selective shortage. Will artificial intelligence tip the scale? If so, in which direction(s) and which settings of care?

Dave Berkus’s quip might define the most significant transition in buying and selling medications since the inception of pharmacy benefit managers.

The Emerging Practice Model Is Having a Moment in Popular Culture. What Is It and What Is the Role of Pharmacy?

Many factors lead to policy change and market viability, but none more than perceived need and desire to receive a service.

Don’t be asleep at the wheel. AI is coming, and it’s coming fast.

Another bill, another day for the erosion of pharmacy benefits as a means of affording a prescription.

Arkansas' "shot heard round the pharmacy world": Preventing pharmacy benefit managers from owning pharmacies raises an interesting question for the field.

Yes. But that doesn’t tell the whole story.

The time frame concept is an underappreciated through line in most planning efforts.

Conventional wisdom on growing old is getting a second look.

COVID-19 changed the personal and professional lives of all pharmacy workforce members. But what now?

A politically and economically stressed system of health care delivery and benefits is manifesting in the pharmacy benefit management sector.

Exponential growth in development is unsustainable in biological systems. But what about AI?

There has never been such widespread and popularized use of compounded products due to shortages. Will consumers rise up with pitchforks if the party is shut down?

Criticism and inquiry are coming from all directions. Will investors earn more by holding on to the past or transitioning toward the future?

Blaming community pharmacies and community pharmacists for a lack of expedited practice evolution is naive at best, and disingenuous or outright malicious at worst.

Pharmacy is at a fork in the road. Business owners, investors, and (hopefully) practicing pharmacists will have a say in which direction the profession takes

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Pharmacists and Pharmacy Advocates Have Been Calling for Pharmacist Practitioner Scope of Practice and Reimbursement for Decades, but What Happens When We Catch the Bus?

Patients, Consumers, and Caregivers Are Increasingly Interested in Self-Determination and Convenience.

Community-based pharmacists performed mightily at a cost-efficient scale and safety record that rivaled any in the history of health professions.

All fills are not equal in their complexity and cost.

With the rest of the retail world catching up with pharmacy queuing, will it change customer expectations at the counter?

Pharmacy technicians are evolving to new roles, working with new teammates

Despite the economic and structural support, rural, poor, and underserved communities still have wide disparities in health outcomes.

Our wacky health care system can’t pay pharmacies a few more dollars to survive, but we can spend billions of dollars on shipping costs.

Frustrations with the current means of achieving price discrimination have reached a boiling point, but the future remains uncertain.

The pharmacy is no longer considered to offer full service (or to be financially sustainable) without a robust vaccination practice.